Viewing nowRosuvastatin Calcium 5 mg Tablet
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Geonil Biopharm Co., Ltd.

MFDS item code 201604058 · Approved 2016.06.29 · Insurance code 073001280
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is an adjunct therapy used for patients with primary hypercholesterolemia and mixed hyperlipidemia when diet and exercise alone do not achieve adequate control. It is also used as an adjunct to dietary therapy or other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia. In patients with hypercholesterolemia, it helps lower total cholesterol and LDL-cholesterol levels, thus slowing the progression of atherosclerosis. It is also used as an adjunct to diet in patients with primary dysbetalipoproteinemia. Furthermore, it contributes to reducing the risk of stroke, myocardial infarction, and arterial revascularization in men over the age of 50 and women over the age of 60 with high levels of high-sensitivity C-reactive protein. This medicine is effectively used for treating hyperlipidemia and reducing the risk of cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, regardless of meals. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine at 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
This medication should not be administered to certain patients. For example, those who are allergic to this drug, those with severely impaired liver function, those with muscle disorders, and those taking certain medications should not use this drug. Additionally, pregnant or breastfeeding women, or women of childbearing potential who are not using appropriate contraception must consult a physician before taking this medication and consider the risks to the fetus. This medication can affect liver function; therefore, individuals with a history of liver disease or those who consume large amounts of alcohol should have regular liver function tests before and during treatment. If symptoms such as muscle pain, weakness, or related muscle symptoms occur, notify a physician immediately, and in severe cases, the use of this medication may need to be discontinued. Those with reduced kidney function or hypothyroidism should be particularly cautious. This medication may interact with some drugs, increasing serum concentrations, so inform your healthcare provider about any current medications. Avoid using it in combination with certain medications. Pregnant or breastfeeding individuals should not use this drug, and women who might become pregnant should employ appropriate contraception while using this drug. In case of an overdose, there is no specific antidote, so treatment should be symptomatic and liver function and muscle enzyme levels should be monitored. Lastly, caution is advised during driving or operating machinery, as dizziness may occur. Finally, if severe rash, itching, fever, or other symptoms appear during treatment, consult a physician immediately, and discontinuation may be necessary if serious skin reactions are suspected.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular muscle weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia and systemic symptoms associated with drug reaction syndrome, drug eruption resembling psoriasis, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, sensory abnormalities, discomfort in the chest, anorexia, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air or moisture, and it is best kept at room temperature between 1 and 30 degrees Celsius. Storing it this way can help maintain its effectiveness for a longer period.
Yellow round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Geonil Biopharm Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.